Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Language
Publication year range
1.
Enferm. nefrol ; 17(3): 175-185, jul.-sept. 2014. tab
Article in Spanish | IBECS | ID: ibc-127136

ABSTRACT

Introducción: La consulta de enfermería es una herramienta imprescindible en el tratamiento sustitutivo renal al proporcionar al paciente y familia los conocimientos necesarios para el autocuidado. La kalemia y la ganancia ponderal constituyen 2 de las variables con mayor asociación a morbi-mortalidad. Objetivo: Evaluar la eficacia de la consulta de enfermería sobre kalemia y ganancia ponderal del paciente en hemodiálisis. Material y métodos: Estudio descriptivo y retrospectivo, realizado en 121 pacientes en programa de Hemodiálisis del Hospital Parc Taulí. Se analizó: - La kalemia previa a la consulta de enfermería y a los 2, 4 y 6 meses de la intervención estratificando en función de si recibe tratamiento farmacológico. - La ganancia de peso inter-diálisis de 14 sesiones pre-consulta de enfermería y 14 posteriores, considerando si mantenían diuresis. Resultados: n Kalemia: · De los 51 pacientes con hiperkalemia en basal, mejoran a los 2 meses post intervención un 68,61% sin cambios en el tratamiento farmacológico. Resultados que se mantenían a los 4 y 6 meses. · Estratificando la muestra: K= 5’1-5’5 mEq/l mejoran en un 67.85%, K > 5’5-6’5 mEq/l un 72,99%, K > 6’5 mEq/l el 100%. · Ganancia ponderal: · Pacientes que pre-consulta de enfermería acumulaban > 2 kg después de la intervención mejoran en un 52.45%. De este grupo solo el 16.39% mantenía diuresis y de estos mejoran un 60%. Conclusiones: Los resultados obtenidos demuestran la eficacia de la consulta de enfermería ya que tanto la hiperkalemia como la hipervolemia disminuyen de modo significativo tras la intervención, pudiendo reducir la morbi-mortalidad de nuestros pacientes (AU)


Introduction: Nursing consultation is an indispensable tool in renal replacement therapy by providing the knowledge necessary for the self-management of the patient and family. Kalemia and weight gain are two of the variables with greater association with morbi-mortality. Alm: To evaluate the effectiveness of nursing consultation regarding kalemia and weight gain in hemodialysis patients. Material and methods: Descriptive and retrospective study conducted in 121 patients in hemodialysis program of the Parc Taulí Hospital. Were analyzed: - Kalemia before nursing consultation and at 2, 4 and 6 months after intervention stratified according to the presence of drug treatment - Interdialytic weight gain of 14 sessions before and after the nursing consultation, considering whether patients maintained diuresis. Results: n Kalemia: · 68.61% of the 51 patients with hyperkalemia at baseline improved at 2 months post-intervention, without changes in drug treatment. Results were maintained at 4 and 6 months. · Stratifying the sample: K = 5'1-5'5 mEq / l were improved at 67.85%, K > 5'5-6'5 mEq / l at 72.99% and K > 6.5 mEq / l at 100 %. n Weight gain: · Patients before nursing consultation accumulated more than 2 kg improved post-intervention in 52.45%. Conclusions: Results demonstrate the effectiveness of the nursing consultation because after the intervention was significantly decreased hyperkalemia and hypervolemia, reducing the morbimortality of our patients (AU)


Subject(s)
Humans , Male , Female , Office Nursing/standards , Office Nursing/trends , Renal Dialysis/nursing , Weight Gain/physiology , Treatment Outcome , Evaluation of the Efficacy-Effectiveness of Interventions , Retrospective Studies , 28599
2.
Enferm Clin ; 20(1): 54-63, 2010.
Article in Spanish | MEDLINE | ID: mdl-20153228

ABSTRACT

Breast cancer is a very important public health issue, due its high incidence and mortality. Neoadjuvant chemotherapy has proven to be a valid option in the treatment of operable breast cancer and a better aesthetic result if breast- tumour ratio is unfavourable. The administration of the therapy itself is complicated, but the difficulty lies mainly in the management of side effects or adverse effects of the treatment. The emergence of a new therapeutic applications need to be constantly reviewed, which combined with the high work loads in the oncology day hospital requires easily managed, standardised and updated methodologies. A method of choice would be the use of clinical pathways that are just emerging in Spain, but could be helpful in managing this disease. The aim of this publication is to share the design of a clinical path for this specific disease with the scientific community. The process of preparing this document has been work of reflection, literature review and unification of criteria that may be used to facilitate work within the Oncology Day Hospital, improving the records of the work involved, especially those related to nursing practice. Their evaluation would enable proposals to be defined for improving and facilitating evidence-based practice.


Subject(s)
Breast Neoplasms/drug therapy , Critical Pathways , Chemotherapy, Adjuvant , Disease Progression , Female , Humans , Neoadjuvant Therapy
3.
Enferm. clín. (Ed. impr.) ; 20(1): 54-63, ene.-feb. 2010. ilus
Article in Spanish | IBECS | ID: ibc-81445

ABSTRACT

El cáncer de mama es un problema de salud pública muy importante, tanto por su alta incidencia como por la mortalidad que ocasiona. La quimioterapia neoadyuvante ha demostrado ser una opción válida en el tratamiento del cáncer de mama operable con un mejor resultado estético en caso de una relación tumor-mama no favorable. La administración de la terapia en sí es complicada, pero su dificultad radica sobre todo en el manejo de los efectos secundarios o adversos del propio tratamiento. La aparición de nuevos esquemas terapéuticos demanda una revisión constante que, unida a las elevadas cargas de trabajo en los hospitales de día oncológicos, requiere de metodologías que dispongan de actuaciones estandarizadas y actualizadas para su manejo. Una metodología de elección sería el uso de trayectorias clínicas, que en España es incipiente, pero podría ser de gran ayuda en el manejo de este tipo de patología. El objetivo de la presente publicación es compartir con la comunidad científica el diseño de una trayectoria clínica específica para este tipo de pacientes. El proceso de elaboración de este documento supuso un esfuerzo de reflexión, revisión bibliográfica y unificación de criterios, un reto que seguro podrá facilitar el trabajo en el Hospital de Día de Oncología del centro, mejorando los registros de las tareas realizadas, sobre todo las relacionadas con la práctica enfermera; su evaluación permitirá definir propuestas de mejora y facilitar la práctica basada en la evidencia(AU)


Breast cancer is a very important public health issue, due its high incidence and mortality. Neoadjuvant chemotherapy has proven to be a valid option in the treatment of operable breast cancer and a better aesthetic result if breast- tumour ratio is unfavourable. The administration of the therapy itself is complicated, but the difficulty lies mainly in the management of side effects or adverse effects of the treatment. The emergence of a new therapeutic applications need to be constantly reviewed, which combined with the high work loads in the oncology day hospital requires easily managed, standardised and updated methodologies. A method of choice would be the use of clinical pathways that are just emerging in Spain, but could be helpful in managing this disease. The aim of this publication is to share the design of a clinical path for this specific disease with the scientific community. The process of preparing this document has been work of reflection, literature review and unification of criteria that may be used to facilitate work within the Oncology Day Hospital, improving the records of the work involved, especially those related to nursing practice. Their evaluation would enable proposals to be defined for improving and facilitating evidence-based practice(AU)


Subject(s)
Humans , Female , Breast Neoplasms/drug therapy , Critical Pathways , Chemotherapy, Adjuvant , Disease Progression , Neoadjuvant Therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...